4//SEC Filing
Rajangam Kanya 4
Accession 0001209191-23-053006
CIK 0001764974other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:41 PM ET
Size
5.7 KB
Accession
0001209191-23-053006
Insider Transaction Report
Form 4
Rajangam Kanya
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+8,012→ 8,012 totalExercise: $2.61Exp: 2033-10-15→ Common Stock (8,012 underlying)
Footnotes (1)
- [F1]Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Turnstone Biologics Corp.
CIK 0001764974
Entity typeother
Related Parties
1- filerCIK 0001816676
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:41 PM ET
- Size
- 5.7 KB